Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ: KMTS · Real-Time Price · USD
27.15
-0.37 (-1.34%)
At close: Dec 26, 2025, 4:00 PM EST
27.13
-0.02 (-0.07%)
After-hours: Dec 26, 2025, 4:10 PM EST

Company Description

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company.

It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected.

The company’s develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.

Its platform provides ASSURE WCD, a wearable cardioverter defibrillator used to protect patients at an elevated risk of sudden cardiac arrest; and a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes.

The company was founded in 2014 and is based in Kirkland, Washington.

Kestra Medical Technologies, Ltd.
Kestra Medical Technologies logo
CountryUnited States
Founded2014
IPO DateMar 6, 2025
IndustryMedical Instruments & Supplies
SectorHealthcare
Employees330
CEOBrian Webster

Contact Details

Address:
3933 Lake Washington Blvd NE, Suite 200
Kirkland, Washington 98033
United States
Phone425 279 8002
Websitekestramedical.com

Stock Details

Ticker SymbolKMTS
ExchangeNASDAQ
Fiscal YearMay - April
Reporting CurrencyUSD
IPO Price$17.00
CIK Code1877184
CUSIP NumberG52441105
ISIN NumberBMG524411052
SIC Code3841

Key Executives

NamePosition
Brian WebsterFounder, President, Chief Executive Officer and Director
Traci S. UmbergerCo-Founder, General Counsel, Chief Administrative Officer, Secretary and Director
Vaseem MahboobChief Financial Officer
Gordon TeddyChief Information Officer
Neil BhalodkarVice President of Investor Relations
Debra SchotzSenior Vice President of Marketing
Jeffrey LaubSenior Vice President of Operations
Phillip D. Foshee Jr.Senior Vice President of Research and Development
Alfred J. Ford Jr.Chief Commercial Officer
Timothy P. MoranChief Business Officer

Latest SEC Filings

DateTypeTitle
Dec 11, 202510-QQuarterly Report
Dec 11, 20258-KCurrent Report
Dec 4, 20258-KCurrent Report
Dec 3, 2025424B4Prospectus
Dec 2, 2025EFFECTNotice of Effectiveness
Dec 2, 2025S-1MEFRegistration adding securities to prior Form S-1 registration
Dec 1, 2025S-1General form for registration of securities under the Securities Act of 1933
Dec 1, 20258-KCurrent Report
Nov 10, 20258-KCurrent Report
Oct 29, 2025DRS[Cover] Draft Registration Statement